Cargando…

Roles of NAD(+) in Acute and Chronic Kidney Diseases

Nicotinamide adenine dinucleotide (oxidized form, NAD(+)) is a critical coenzyme, with functions ranging from redox reactions and energy metabolism in mitochondrial respiration and oxidative phosphorylation to being a central player in multiple cellular signaling pathways, organ resilience, health,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morevati, Marya, Fang, Evandro Fei, Mace, Maria L., Kanbay, Mehmet, Gravesen, Eva, Nordholm, Anders, Egstrand, Søren, Hornum, Mads
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820289/ https://www.ncbi.nlm.nih.gov/pubmed/36613582 http://dx.doi.org/10.3390/ijms24010137

Ejemplares similares

The Calcified Vasculature in Chronic Kidney Disease Secretes Factors that Inhibit Bone Mineralization
por: Mace, Maria L., et al.
Publicado: (2022)

Effect of NAD(+) boosting on kidney ischemia-reperfusion injury
por: Morevati, Marya, et al.
Publicado: (2021)

Circadian rhythm of activin A and related parameters of mineral metabolism in normal and uremic rats
por: Nordholm, Anders, et al.
Publicado: (2019)

Chronic Kidney Disease–Induced Vascular Calcification Impairs Bone Metabolism
por: Mace, Maria L, et al.
Publicado: (2020)

New Insights to the Crosstalk between Vascular and Bone Tissue in Chronic Kidney Disease–Mineral and Bone Disorder
por: Mace, Maria L., et al.
Publicado: (2021)

Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications
por: Gravesen, Eva, et al.
Publicado: (2018)

A potential kidney - bone axis involved in the rapid minute-to-minute regulation of plasma Ca(2+)
por: Nordholm, Anders, et al.
Publicado: (2015)

Extrarenal expression of α-klotho, the kidney related longevity gene, in Heterocephalus glaber, the long living Naked Mole Rat
por: Morevati, M., et al.
Publicado: (2021)

The Vascular Circadian Clock in Chronic Kidney Disease
por: Egstrand, Søren, et al.
Publicado: (2021)

Fibroblast Growth Factor (FGF) 23 Regulates the Plasma Levels of Parathyroid Hormone In Vivo Through the FGF Receptor in Normocalcemia, But Not in Hypocalcemia
por: Mace, Maria L., et al.
Publicado: (2017)

Diurnal variation of magnesium and the mineral metabolism in patients with chronic kidney disease
por: Jacobsen, Alexanndra A., et al.
Publicado: (2021)

Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification
por: Gravesen, Eva, et al.
Publicado: (2018)

Mitophagy and NAD(+) inhibit Alzheimer disease
por: Fang, Evandro F.
Publicado: (2019)

Ascorbic acid: a promising agent in chronic kidney disease?
por: Karahan, Salih, et al.
Publicado: (2018)

Targeting on the NAD(+)‐mitophagy axis to treat cardiovascular disease
por: Fang, Evandro F., et al.
Publicado: (2020)

NAD(+) augmentation restores mitophagy and limits accelerated aging in Werner syndrome
por: Fang, Evandro F., et al.
Publicado: (2019)

Bone morphogenic protein-7: a new prognostic marker for acute kidney injury?
por: Kanbay, Mehmet, et al.
Publicado: (2010)

An Update on Coronary Artery Disease and Chronic Kidney Disease
por: Afsar, Baris, et al.
Publicado: (2014)

Turning up the NAD(+)-mitophagy axis to treat Alzheimer’s disease
por: Fang, Evandro F., et al.
Publicado: (2022)

Increase in the global burden of chronic kidney disease: might it be attributable to air pollution?
por: Copur, Sidar, et al.
Publicado: (2022)

Is relative overhydration measurement by bioimpedance spectroscopy useful in reducing morbidity and mortality in chronic kidney disease?
por: Karaaslan, Doruk C, et al.
Publicado: (2018)

Visit-to-visit blood pressure variability and risk of dementia in chronic kidney disease patients: why are blood pressure changes so important in cognitive functions?
por: Yavuz, Furkan, et al.
Publicado: (2022)

De novo NAD+ biosynthetic impairment in acute kidney injury in humans
por: Mehr, Ali Poyan, et al.
Publicado: (2018)

A promising tool: triglyceride–glucose index to stratify the risk of cardiovascular events in chronic kidney disease
por: Yildirim, Fatma, et al.
Publicado: (2022)

Acute kidney injury in hospitalized COVID-19 patients
por: Kanbay, Mehmet, et al.
Publicado: (2021)

The chaos of hypertension guidelines for chronic kidney disease patients
por: Castillo-Rodriguez, Esmeralda, et al.
Publicado: (2019)

The significance of NAD + metabolites and nicotinamide N-methyltransferase in chronic kidney disease
por: Takahashi, Rina, et al.
Publicado: (2022)

NAD(+) Metabolism and Interventions in Premature Renal Aging and Chronic Kidney Disease
por: Chanvillard, Lucie, et al.
Publicado: (2022)

The assessment of hypertension in kidney transplant patients: time to change our approach?
por: Demiray, Atalay, et al.
Publicado: (2021)

Post-acute COVID-19 syndrome and kidney diseases: what do we know?
por: Copur, Sidar, et al.
Publicado: (2022)

NAD(+) Homeostasis in Diabetic Kidney Disease
por: Xu, Jing, et al.
Publicado: (2021)

A Decade of Global mRNA and miRNA Profiling of HPV-Positive Cell Lines and Clinical Specimens
por: Kaczkowski, Bogumil, et al.
Publicado: (2012)

Air pollution and kidney disease: review of current evidence
por: Afsar, Baris, et al.
Publicado: (2018)

Serum uric acid and acute kidney injury: A mini review
por: Hahn, Kai, et al.
Publicado: (2017)

NAD+ Biosynthesis Impairment and Acute Kidney Injury after Major Vascular Surgery
por: Mede, Annmarie I., et al.
Publicado: (2023)

Early aging and premature vascular aging in chronic kidney disease
por: Tanriover, Cem, et al.
Publicado: (2023)

Kidney disease and electrolytes in COVID-19: more than meets the eye
por: Carriazo, Sol, et al.
Publicado: (2020)

High dose intravenous iron, mineral homeostasis and intact FGF23 in normal and uremic rats
por: Gravesen, Eva, et al.
Publicado: (2013)

Elevated suPAR Is an Independent Risk Marker for Incident Kidney Disease in Acute Medical Patients
por: Iversen, Esben, et al.
Publicado: (2020)

Cardiovascular mortality in patients with advanced chronic kidney disease with and without diabetes: a nationwide cohort study
por: Kofod, Dea Haagensen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hoalgu949uqlscvdegs6jg9l0c